First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXHFirst TrustHealthETFUSD
Market open · Delayed 15 min · as of Oct 9, 1:14 PM ET
FTXH chart
Full chartKey facts
- Expense ratio
- 0.60%
- Assets (AUM)
- $1.06B
- Dividend yield
- 0.70%
- Holdings
- 10
- Inception
- Sep 20, 2016
- Issuer
- First Trust
- Index tracked
- —
- Category
- Health
- 52-week range
- 28.77 – 43.52
- Volume / Avg
- 49.03K / 681.63K
- Beta
- —
- Previous close
- 40.45
FTXH ETF today
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund from First Trust in the Health category. It charges an expense ratio of 0.60%, or $60.00 per year on a $10,000 investment, and manages $1.06 billion in assets. Its largest holding is AbbVie Inc (ABBV) at 7.30% of assets, and the top 10 positions make up 54.0% of the portfolio out of 10 holdings.
The fund's trailing dividend yield is 0.70% ($0.00 per share annually). FTXH launched on Sep 20, 2016.
Summary generated from market data by MetaCap's automated system. Methodology
FTXH top 10 holdings
FTXH performance
1 week
-0.55%
FTXH price return, excluding dividends.
ETFs similar to FTXH
FTXH news
All FTXH newsFTXH ETF FAQ
What is the FTXH price today?
FTXH last traded at $41.26 as of Oct 9, 1:14 PM EDT, up 2.00% on the day.
What is FTXH's expense ratio?
FTXH has an expense ratio of 0.60%, which works out to about $60.00 per year for every $10,000 invested.
What are FTXH's top holdings?
FTXH's largest holdings are AbbVie Inc (7.30%), Pfizer Inc (7.17%), Eli Lilly and Co (7.16%), Johnson & Johnson (7.13%), Merck & Co Inc (7.04%). The top 10 make up 54.0% of the fund.
Does FTXH pay a dividend?
Yes. FTXH has a trailing dividend yield of 0.70%.
How big is FTXH?
FTXH has about $1.06 billion in assets under management spread across 10 holdings.